Seven digital health technologies that could help millions of people with lower back pain have been recommended for NHS in draft guidance published by cost-effectiveness o
In the last UK election in 2019, the NHS emerged as a major talking point, as the scale of the country’s support of the service was brought to the fore.
AstraZeneca and Daiichi Sankyo’s Enhertu should not be made available via the NHS for HER2-low metastatic or unresectable breast cancer after chemotherapy, according to pr